EndoGastric Solutions Gets $21.5M

Redwood City-based EndoGastric Solutions, a developer of medical devices for treating gastroesophageal reflux disease (GERD), has raised $21.5M in a Series E funding round. The funding came from current investors. The company said that the round will go to expand its commercial presence in the market. The company has previously raised funding from Advanced Technology Ventures, Chicago Growth Partners, Foundation Medical Partners,MPM Capital, Oakwood Medical Investors, and De Novo Ventures.